Extend your dog’s vitality — and help others too

Our study explores a gene therapy that could reduce arthritis symptoms and preserve mobility in aging dogs. Your companion may benefit — and contribute to research that helps countless others.

Gradient illustration of a dog with head tilted upward in warm light

How it works,
step by step.

Participation is simple, transparent, and designed to support you and your dog every step of the way. You remain your dog’s primary caregiver throughout, while gaining access to veterinary oversight, regular check-ins, and the opportunity to contribute to meaningful, real-world research.

1. Apply to our research program

Start by telling us about yourself and your dog through the short registration form below. This helps us assess eligibility and keep you updated as enrollment progresses.

Anyone is welcome to register, regardless of location or your dog’s age. For this first study, we’ll be focusing on older dogs or those already showing signs of a degenerative condition. The study will be conducted in partnership with veterinary clinics in the San Francisco, Los Angeles, New York, Boston, and Orlando regions.

Man sitting on steps, cuddling a Basset Hound in afternoon light
Woman smiling at a laptop with two dogs beside her on the couch

2. Informed Consent

When we’re ready to officially enroll, we’ll contact you with a short set of follow-up questions. If your dog meets the criteria, we’ll schedule a call to go through the informed consent process.

On the call, you’ll receive detailed information about the study, have the chance to ask questions, and take time to decide before moving forward.

3. Begin the protocol

Before the study begins, you’ll receive a biometric collar for your dog along with a short questionnaire.

Once we’ve collected the baseline data, we’ll schedule the treatment. Over the following year, you and your dog will attend four follow-up appointments to track progress and outcomes.You may also choose to opt in to additional testing — such as MRI or genomic analysis.

Happy husky at the vet on an exam table with a clinician in scrubs nearby
Woman holding a Shiba Inu while reading her smartphone by a window

4. Share insights

In addition to structured follow up appointments with our partner network, you and your companion will complete regular online check-ins that give us anecdotal data points on your dog's mobility, energy, and general health. You know your best friend better than anyone, so your reading of their habits and mood is essential in tracking the progress of the therapy.

FAQs

Is this safe for my dog?

The follistatin therapy has been tested in human clinical trials with no serious adverse events. All procedures follow strict veterinary safety protocols.

Where will the study take place?

The study will be conducted in The United States, in partnership with veterinary clinics in the San Francisco, Los Angeles, New York, Boston, and Orlando regions.

What conditions qualify?

Dogs experiencing age-related changes including arthritis, reduced mobility, or other degenerative conditions may be eligible.

When will the study begin?

We're currently finalizing regulatory approvals. Pre-registered participants will be notified first when enrollment opens.

What's the time commitment?

The core study lasts 12 months, with optional extended follow-up. Participants receive comprehensive veterinary care and monitoring throughout.

Do I get paid for participating in the trials?

No, participants are not paid for joining the study. However, those who complete the trial with no more than one missed appointment may receive tokens. These tokens don’t have cash value, but they do give you a voice in how your dog’s data is used, ensuring you remain part of the decision-making process.

Be the first to know when enrollment begins.

Pre-register below to find out if your dog may qualify for our upcoming gene therapy study. There’s no obligation — just the opportunity to learn more and stay informed.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.